Status:

UNKNOWN

Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant

Lead Sponsor:

Hospital Israelita Albert Einstein

Conditions:

Blood Coagulation Disorders

Evidence of Liver Transplantation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

A point-of-care bleeding management protocol based on global viscoelastic test (thromboelastometry) can change the amount of blood products used during orthotopic liver transplant.

Detailed Description

Patients with liver disease frequently acquire a complex disorder of hemostasis secondary to their disease. The fundamental key to the management of coagulopathy of cirrhotic patient is the knowledge...

Eligibility Criteria

Inclusion

  • all patients from the national list of liver transplant assigned to have their transplant in Hospital Israelita Albert Einstein who gave free and clarified consent term.

Exclusion

  • acute liver failure
  • age under 18
  • combined transplant
  • re transplantation less than 30 days
  • incomplete medical records, more than 20% of missing data.

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2016

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT02239991

Start Date

September 1 2014

End Date

February 1 2016

Last Update

September 17 2014

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hospital Israelita Albert Einstein

São Paulo, São Paulo, Brazil, 05652-000

2

Hospital Israelita Albert Einstein

São Paulo, São Paulo, Brazil, 05652-900

Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant | DecenTrialz